SHAKER A. MOUSA
Chairman
Pharmaceutical Research Institute
USA
Biography
Shaker A Mousa has completed his PhD from Ohio State University, College of Medicine in Columbus and Postdoctoral Fellowship from University of Kentucky in Lexington. He also has completed his MBA from Widener University, Chester, PA. He is currently an endowed tenure Professor and Executive Vice-President and Chairman of the Pharmaceutical Research Institute and Vice Provost for Research at ACPHS. He holds over 350 US and international patents discovering novel anti-angiogenesis strategies, anti-thrombotic, anti-integrin, anti-cancer and non-invasive diagnostic imaging approaches employing various nanotechnology platforms. He has published more than 1,000 journal articles, book chapters, published patents and books as editor and author. He is a Member of several NIH study sections and the Editorial Board of several high impact journals. His research has focused on diagnostics and therapeutics of angiogenesis-related disorders, thrombosis, vascular and cardiovascular diseases.
Research Interest
Adhesion molecules in health and diseases, Novel therapeutic and diagnostic targets, Treatment and prevention of ischemic and coronary artery diseases, Angiogenesis modulation, vascular and tissue remodelling, and novel anti-platelet, anti-thrombotic and anti-ischemic therapies.